Skip to Main Content

TDH Update on Investigation of Adverse Events among Patients Receiving Methylprednisolone Acetate Injections

Friday, May 24, 2013 | 10:17am

NASHVILLE – The Tennessee Department of Health will host a media briefing via telephone conference on reports of adverse events among patients in Illinois and North Carolina who received injections of methylprednisolone acetate produced by Main Street Family Pharmacy, LLC, in Newbern, Tenn. The briefing will take place on Friday, May 24 at 4 p.m. Central time. Media members may participate in the briefing via telephone by calling 1-888-757-2790, passcode 781337.

Participants in this conference call are asked to mute their phones after joining the call as a courtesy to other participants, and may unmute phones to ask questions. Participants should not put the call on hold at any time.

 

Who:  John Dreyzehner, MD, MPH, Commissioner, Tennessee Department of Health

Tim Jones, MD, State Epidemiologist, Tennessee Department of Health

Marion Kainer, MD, MPH, Director, Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health

Michelle J. Long, JD, Assistant Commissioner for Health Licensure and Regulation, Tennessee Department of Health

What:   Update on investigation of adverse events associated with MPA injections

                                When:  Friday, May 24, 4 p.m. Central time

                                Call-in information:  Call 1-888-757-2790, Passcode:  781337

MEDIA CONTACTS:  Woody McMillin, 615.741.3446 or Woody.McMillin@tn.gov OR Shelley Walker, 615.253.5184 or Shelley.Walker@tn.gov.

 

Media Advisories | Press Releases